Literature DB >> 2184697

Skeletal structural adaptations to mechanical usage (SATMU): 4. Mechanical influences on intact fibrous tissues.

H M Frost1.   

Abstract

This paper proposes that the growth in length of living fibrous tissue structures (tendon, ligament, fascia) responds primarily to circulating systemic rather than mechanical factors. However, growth of the thickness of those structures responds primarily to their mechanical tension loads in the special sense that, when the tissue's typical peak mechanical strains exceed a threshold value, its cells begin to add new collagen to increase its thickness, strength, and tension stiffness. When subsequent peak strains reduce to the threshold value, then further additions of collagen stop. That process defines mechanically controlled modeling of fibrous tissues. The collagen in these tissues can also develop mechanical microdamage (MDx) under repeated tension load-deload cycles. Special maintenance mechanisms normally repair that MDx to prevent accumulations that would threaten structural integrity. As a result, spontaneous complete ruptures of these structures can happen when MDx production exceeds its repair. These maintenance mechanisms also prevent gradual stretching under continuous tension loads, a process the author suggests calling creep compensation. When the creep compensation mechanism becomes incompetent, structures can stretch under continuous loads; when it becomes overactive, contractures can occur. The above meld of fact and inference provides the kernel of a general theory for the responses of the architecture and mechanical competence of intact fibrous tissues to mechanical usage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2184697     DOI: 10.1002/ar.1092260405

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  20 in total

1.  Organization and distribution of intramuscular connective tissue in normal and immobilized skeletal muscles. An immunohistochemical, polarization and scanning electron microscopic study.

Authors:  Tero A H Järvinen; Laszló Józsa; Pekka Kannus; Teppo L N Järvinen; Markku Järvinen
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

Review 2.  Some ABC's of skeletal pathophysiology. 8. The trivial/physiologic/pathologic distinction.

Authors:  H M Frost
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

3.  Regulation of gene expression in intervertebral disc cells by low and high hydrostatic pressure.

Authors:  Cornelia Neidlinger-Wilke; Karin Würtz; Jill P G Urban; Wolfgang Börm; Markus Arand; Anita Ignatius; Hans-Joachim Wilke; Lutz E Claes
Journal:  Eur Spine J       Date:  2006-05-06       Impact factor: 3.134

4.  Some ABC's of skeletal pathophysiology. 5. Microdamage physiology.

Authors:  H M Frost
Journal:  Calcif Tissue Int       Date:  1991-10       Impact factor: 4.333

5.  Some ABC's of skeletal pathophysiology. 6. The growth/modeling/remodeling distinction.

Authors:  H M Frost
Journal:  Calcif Tissue Int       Date:  1991-11       Impact factor: 4.333

6.  Histological evidence for muscle insertion in extant amniote femora: implications for muscle reconstruction in fossils.

Authors:  Holger Petermann; Martin Sander
Journal:  J Anat       Date:  2013-02-25       Impact factor: 2.610

Review 7.  Physiological mechanisms and therapeutic potential of bone mechanosensing.

Authors:  Zhousheng Xiao; Leigh Darryl Quarles
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

8.  Perspectives: on a "paradigm shift" developing in skeletal science.

Authors:  H M Frost
Journal:  Calcif Tissue Int       Date:  1995-01       Impact factor: 4.333

9.  Suggested fundamental concepts in skeletal physiology.

Authors:  H M Frost
Journal:  Calcif Tissue Int       Date:  1993-01       Impact factor: 4.333

10.  Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase.

Authors:  Ilaria Roato; Francesco Porta; Alessandro Mussa; Lucia D'Amico; Ludovica Fiore; Davide Garelli; Marco Spada; Riccardo Ferracini
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.